Outcomes of internal hemipelvectomy for pelvic tumors: a developing country’s prospective

Abstract

Introduction:Previously, external hemipelvectomy was the mainstay of treatment for pelvic tumors. However, with technological advancements, limb salvage procedures such as internal hemipelvectomy have emerged as a viable alternative. However, there is limited literature available on long-term outcomes and complications of internal hemipelvectomy, especially from developing countries. Therefore, the objective of this study was to share our experience of internal hemipelvectomy at a tertiary care center in a developing country.Materials and methods:A retrospective review was conducted in which all 24 patients undergoing internal hemipelvectomy from January 1, 2005 to December 31, 2015 at our institution were included. Medical record files were reviewed for intraoperative and early and late postoperative complications, and functional outcomes were assessed by contacting each patient on telephone.Results:Ewing sarcoma was found to be the most common diagnosis, followed by osteosarcoma as the second most common. The mean follow-up period was 18.7±13.9 months. Intraoperatively there were 4 cases of iatrogenic neurovascular injury and 2 cases each of urinary tract injury and dural tear. Four patients developed early wound infections, 7 developed late wound infections, and 2 developed flap necrosis. Three patients developed recurrence, whereas 7 patients developed metastasis postoperatively. The mean survival was calculated to be 28 months and the mean Musculoskeletal Tumor Society score was 19.3±5.2.Conclusions:Outcomes and prevalence of complications shown in this study are comparable to those in the international literature, which suggests that hemipelvectomy is a viable option in developing countries also. However, more such studies are warranted to validate the findings and to identify the challenges and morbidities associated with hemipelvectomy in Asian and developing countries.

Gigantic secondary pelvic chondrosarcomas treated with pelvic resection type I and III: A case report

“…A study by Umer et al showed that the mean surgery time in pelvic resection was 356 min and the mean intraoperative blood loss was 1900 cc. Meanwhile, that study also showed that 62.5% of the tumor diameter was less than 10 cm [ 3 ]. Therefore, honed surgical and intraoperative bleeding control skills, which would result in less surgery time and blood loss, were substantial.…”

“…Han et al showed that the surgical margin was the factor most closely related to the local recurrence [ 29 ]. Several studies showed local recurrence rate 12,5–19% [ 3 , 30 , 31 ]. However, the patient may require further follow up.…”

“…These tumors also tend to present late and therefore pose a significant challenge for orthopedic oncologists because of the large tumor size, local extension, and complex anatomy with proximity to major neurovascular structures, intestinal, and urinary tracts. Subsequently, these are associated with less favorable prognosis and survival than other extremity tumors [ 3 ]. Even today, pelvic sarcomas treatment remains one of the most predominant challenges for orthopedic oncologists due to the proximity of visceral organs and neurovascular structures [ 4 ].…”

Establishing musculoskeletal oncology service in resource constrained country: challenges and solutions

“…Data management in the form of a formal tumor registry is also being practiced within our section of orthopedics. This has helped us put out numerous publications in the field of musculoskeletal oncology 32 – 47 . We feel that now this experience needs to be replicated on a national level and we are making efforts in this regard.…”

Ewing’s Sarcoma: Approaching Century Since This Bone Cancer Made News

“…Among the issues faced in Pakistan, the most important factors influencing poor outcomes are late referrals, followed by inadequate diagnosis and treatment. [14] Perhaps, one of the most significant barriers in the advancement of therapy is the lack of cancer registries at national level which makes it difficult to gauge the burden of disease and short-/long-term outcomes. [15] The way forward is to utilize the hospital-based registries and provincial data to form minimum diagnostic and therapeutic guidelines, tailored to the needs of our own population.…”